Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Biogen
- License Information
-
More Information
Article History
Received: 4 July 2025
Revised: 31 July 2025
Accepted: 1 August 2025
First Online: 2 September 2025
Declarations
:
: SC served in SAB for Biogen, Novartis, Roche. LO reports no competing interests in relation to this paper. VS participated in SAB for Roche, Biogen, Novartis, and Sarepta. Her work has involved clinical trials and studies related to neuromuscular conditions. No competing interests related to this paper.
